PortfoliosLab logoPortfoliosLab logo
ALKS vs. VYGR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALKS vs. VYGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alkermes plc (ALKS) and Voyager Therapeutics, Inc. (VYGR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALKS achieves a 52.82% return, which is significantly higher than VYGR's -8.40% return. Over the past 10 years, ALKS has outperformed VYGR with an annualized return of -0.52%, while VYGR has yielded a comparatively lower -12.32% annualized return.


ALKS

1D
3.48%
1M
25.14%
YTD
52.82%
6M
44.80%
1Y
36.74%
3Y*
13.16%
5Y*
13.13%
10Y*
-0.52%

VYGR

1D
0.28%
1M
-7.22%
YTD
-8.40%
6M
-14.89%
1Y
9.76%
3Y*
-31.82%
5Y*
-3.08%
10Y*
-12.32%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALKS vs. VYGR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ALKS
Alkermes plc
52.82%-2.71%3.68%6.16%12.34%16.59%-2.21%-30.87%-46.08%-1.53%
VYGR
Voyager Therapeutics, Inc.
-8.40%-30.69%-32.82%38.36%125.09%-62.10%-48.75%48.40%-43.37%30.30%

Correlation

The correlation between ALKS and VYGR is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.34

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (10Y)
Calculated over the trailing 10-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Nov 12, 2015

0.33

Fundamentals

Market Cap

ALKS:

$7.11B

VYGR:

$214.19M

EPS

ALKS:

$0.91

VYGR:

-$1.98

PS Ratio

ALKS:

4.60

VYGR:

5.81

PB Ratio

ALKS:

4.06

VYGR:

1.23

Total Revenue (TTM)

ALKS:

$1.56B

VYGR:

$36.49M

Gross Profit (TTM)

ALKS:

$1.02B

VYGR:

$33.90M

EBITDA (TTM)

ALKS:

$249.70M

VYGR:

-$91.32M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALKS vs. VYGR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALKS
ALKS Risk / Return Rank: 6868
Overall Rank
ALKS Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
ALKS Sortino Ratio Rank: 6767
Sortino Ratio Rank
ALKS Omega Ratio Rank: 6464
Omega Ratio Rank
ALKS Calmar Ratio Rank: 7171
Calmar Ratio Rank
ALKS Martin Ratio Rank: 6868
Martin Ratio Rank

VYGR
VYGR Risk / Return Rank: 4747
Overall Rank
VYGR Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
VYGR Sortino Ratio Rank: 4747
Sortino Ratio Rank
VYGR Omega Ratio Rank: 4646
Omega Ratio Rank
VYGR Calmar Ratio Rank: 4747
Calmar Ratio Rank
VYGR Martin Ratio Rank: 4747
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALKS vs. VYGR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alkermes plc (ALKS) and Voyager Therapeutics, Inc. (VYGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ALKSVYGRDifference
Sharpe ratioReturn per unit of total volatility

+0.76

Sortino ratioReturn per unit of downside risk

+0.85

Omega ratioGain probability vs. loss probability

1.19

1.08

+0.11

Calmar ratioReturn relative to maximum drawdown

1.66

0.26

+1.40

Martin ratioReturn relative to average drawdown

3.50

0.48

+3.02

ALKS vs. VYGR - Sharpe Ratio Comparison

The current ALKS Sharpe Ratio is 0.91, which is higher than the VYGR Sharpe Ratio of 0.15. The chart below compares the historical Sharpe Ratios of ALKS and VYGR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ALKSVYGRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.91

0.15

+0.76

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.35

-0.04

+0.39

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.01

-0.16

+0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.10

-0.18

+0.28

Drawdowns

ALKS vs. VYGR - Drawdown Comparison

The maximum ALKS drawdown since its inception was -96.14%, roughly equal to the maximum VYGR drawdown of -92.11%. Use the drawdown chart below to compare losses from any high point for ALKS and VYGR.


Loading charts...

Drawdown Indicators


ALKSVYGRDifference

Max Drawdown

Largest peak-to-trough decline

-96.14%

-92.11%

-4.03%

Max Drawdown (1Y)

Largest decline over 1 year

-22.20%

-37.34%

+15.14%

Max Drawdown (3Y)

Largest decline over 3 years

-31.58%

-80.49%

+48.91%

Max Drawdown (5Y)

Largest decline over 5 years

-33.18%

-80.49%

+47.31%

Max Drawdown (10Y)

Largest decline over 10 years

-80.58%

-92.11%

+11.53%

Current Drawdown

Current decline from peak

-56.39%

-88.50%

+32.11%

Average Drawdown

Average peak-to-trough decline

-67.25%

-66.87%

-0.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.54%

20.45%

-9.91%

Volatility

ALKS vs. VYGR - Volatility Comparison

The current volatility for Alkermes plc (ALKS) is 13.20%, while Voyager Therapeutics, Inc. (VYGR) has a volatility of 19.03%. This indicates that ALKS experiences smaller price fluctuations and is considered to be less risky than VYGR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALKSVYGRDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.20%

19.03%

-5.83%

Volatility (6M)

Calculated over the trailing 6-month period

30.12%

44.41%

-14.29%

Volatility (1Y)

Calculated over the trailing 1-year period

40.64%

65.82%

-25.18%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

37.32%

80.79%

-43.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

41.29%

75.87%

-34.58%

Dividends

ALKS vs. VYGR - Dividend Comparison

Neither ALKS nor VYGR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ALKS vs. VYGR - Financials Comparison

This section allows you to compare key financial metrics between Alkermes plc and Voyager Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00M600.00M20222023202420252026
392.91M
2.59M
(ALKS) Total Revenue
(VYGR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ALKS and VYGR have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VYGR has higher volatility (19.03%) compared to ALKS (13.20%). In terms of maximum drawdown, ALKS dropped -96.14% vs VYGR's -92.11%.

ALKS currently has the higher Sharpe Ratio (0.91 vs 0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALKS and VYGR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer